Treatment of lymphedema of the arms and legs with 5,6-benzo-[α]-pyrone
Identifieur interne : 00DA52 ( Main/Merge ); précédent : 00DA51; suivant : 00DA53Treatment of lymphedema of the arms and legs with 5,6-benzo-[α]-pyrone
Auteurs : J. R. Casley-Smith [Australie] ; R. G. Morgan ; N. B. PillerSource :
- The New England journal of medicine [ 0028-4793 ] ; 1993.
Descripteurs français
- Pascal (Inist)
- Wicri :
English descriptors
- KwdEn :
Abstract
Background. Benzopyrones can reduce the volume of high-protein edema fluid by stimulating proteolysis. These compounds provide a method for removing excess protein and its consequent edema and reduce its clinical sequelae, such as chronic inflammation and secondary infections. Methods. We conducted a randomized, double-blind, placebo-controlled, crossover trial of 5,6-benzo-[α]-pyrone in 31 patients with postmastectomy lymphedema of the arm and 21 patients with lymphedema of the leg of various causes. This agent is also known as 56 BaP, 1,2-benzopyrone, and coumarin, although it has no anticoagulant activity. The patients received 400 mg of the active drug or placebo, each for six months. Results. During the placebo period, lymphedema often worsened, especially in the arms
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 000D29
- to stream PascalFrancis, to step Curation: 000D79
- to stream PascalFrancis, to step Checkpoint: 000D21
Links to Exploration step
Pascal:94-0003914Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Treatment of lymphedema of the arms and legs with 5,6-benzo-[α]-pyrone</title>
<author><name sortKey="Casley Smith, J R" sort="Casley Smith, J R" uniqKey="Casley Smith J" first="J. R." last="Casley-Smith">J. R. Casley-Smith</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Univ. Adelaide, Henry Thomas lab.</s1>
<s2>Adelaide S. Aust. 5001</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Adelaide S. Aust. 5001</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Morgan, R G" sort="Morgan, R G" uniqKey="Morgan R" first="R. G." last="Morgan">R. G. Morgan</name>
</author>
<author><name sortKey="Piller, N B" sort="Piller, N B" uniqKey="Piller N" first="N. B." last="Piller">N. B. Piller</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">94-0003914</idno>
<date when="1993">1993</date>
<idno type="stanalyst">PASCAL 94-0003914 INIST</idno>
<idno type="RBID">Pascal:94-0003914</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000D29</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000D79</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000D21</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000D21</idno>
<idno type="wicri:doubleKey">0028-4793:1993:Casley Smith J:treatment:of:lymphedema</idno>
<idno type="wicri:Area/Main/Merge">00DA52</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Treatment of lymphedema of the arms and legs with 5,6-benzo-[α]-pyrone</title>
<author><name sortKey="Casley Smith, J R" sort="Casley Smith, J R" uniqKey="Casley Smith J" first="J. R." last="Casley-Smith">J. R. Casley-Smith</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Univ. Adelaide, Henry Thomas lab.</s1>
<s2>Adelaide S. Aust. 5001</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Adelaide S. Aust. 5001</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Morgan, R G" sort="Morgan, R G" uniqKey="Morgan R" first="R. G." last="Morgan">R. G. Morgan</name>
</author>
<author><name sortKey="Piller, N B" sort="Piller, N B" uniqKey="Piller N" first="N. B." last="Piller">N. B. Piller</name>
</author>
</analytic>
<series><title level="j" type="main">The New England journal of medicine</title>
<title level="j" type="abbreviated">N. Engl. j. med.</title>
<idno type="ISSN">0028-4793</idno>
<imprint><date when="1993">1993</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">The New England journal of medicine</title>
<title level="j" type="abbreviated">N. Engl. j. med.</title>
<idno type="ISSN">0028-4793</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiinflammatory agent</term>
<term>Chemotherapy</term>
<term>Follow up study</term>
<term>Human</term>
<term>Lower limb</term>
<term>Lymphatic vessel disease</term>
<term>Lymphedema</term>
<term>Result</term>
<term>Surgery</term>
<term>Treatment</term>
<term>Upper limb</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Lymphatique pathologie</term>
<term>Membre inférieur</term>
<term>Membre supérieur</term>
<term>Résultat</term>
<term>Traitement</term>
<term>Homme</term>
<term>Chimiothérapie</term>
<term>Antiinflammatoire</term>
<term>Chirurgie</term>
<term>Lymphoedème</term>
<term>Etude longitudinale</term>
<term>5,6-Benzo-(α)-pyrone</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
<term>Chirurgie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Background. Benzopyrones can reduce the volume of high-protein edema fluid by stimulating proteolysis. These compounds provide a method for removing excess protein and its consequent edema and reduce its clinical sequelae, such as chronic inflammation and secondary infections. Methods. We conducted a randomized, double-blind, placebo-controlled, crossover trial of 5,6-benzo-[α]-pyrone in 31 patients with postmastectomy lymphedema of the arm and 21 patients with lymphedema of the leg of various causes. This agent is also known as 56 BaP, 1,2-benzopyrone, and coumarin, although it has no anticoagulant activity. The patients received 400 mg of the active drug or placebo, each for six months. Results. During the placebo period, lymphedema often worsened, especially in the arms</div>
</front>
</TEI>
<affiliations><list><country><li>Australie</li>
</country>
</list>
<tree><noCountry><name sortKey="Morgan, R G" sort="Morgan, R G" uniqKey="Morgan R" first="R. G." last="Morgan">R. G. Morgan</name>
<name sortKey="Piller, N B" sort="Piller, N B" uniqKey="Piller N" first="N. B." last="Piller">N. B. Piller</name>
</noCountry>
<country name="Australie"><noRegion><name sortKey="Casley Smith, J R" sort="Casley Smith, J R" uniqKey="Casley Smith J" first="J. R." last="Casley-Smith">J. R. Casley-Smith</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00DA52 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 00DA52 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Main |étape= Merge |type= RBID |clé= Pascal:94-0003914 |texte= Treatment of lymphedema of the arms and legs with 5,6-benzo-[α]-pyrone }}
This area was generated with Dilib version V0.6.31. |